(Q46591692)

23 December 2017

meta-analysis

0 references

title

Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients (English)

1 reference

23 December 2017

5

Dan Atar

1 reference

23 December 2017

6

Charles H Hennekens

1 reference

23 December 2017

author name string

Victor L Serebruany

1

1 reference

23 December 2017

Alex I Malinin

2

1 reference

23 December 2017

James J Ferguson

3

1 reference

23 December 2017

Javad Vahabi

4

1 reference

23 December 2017

publication date

1 June 2008

1 reference

23 December 2017

Fundamental and Clinical Pharmacology

published in

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

315-321

1 reference

23 December 2017

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2008.00582.X

10.1111/J.1472-8206.2008.00582.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017